TECHNOLOGY FACTS

Tissue Expanders Market Strong Development and Huge Growth

According to the Aesthetic Society for Aesthetic Plastic Surgery, breast lift procedures and breast augmentation accounts for 56% of the overall cosmetic expenditures performed in 2016. Increasing number of surgeries has led to increasing demand for the reconstruction of scalp and forehead skin globally. These factors are expected to contribute towards the global market growth of tissue expanders during the forecast period.

Read Report Summary: https://www.factmr.com/report/340/tissue-expanders-market

Increasing number of road accidents lead to various injuries and scars on arms, head, legs and chest. Surge in the number of scars due to increasing number of road accidents is further expected to rev up demand for surgical interventions. According to the World Health Organization, more than 1.25 million people die in road accidents each year. These accidents have significantly led to legs, head, arms and chest injuries globally. Increasing number of road accidents is projected to remain a major factor that has revved up demand for treatment of the accident injuries and scars.

However, breakage or leakage of the silicon expanders is becoming a major concern for the tissue expansion treatment. Growing requirement of replacing the tissue expanders attributed to increasing leakage and spread of saline in the human body continues to increase demand for tissue expanders globally. Such incidences are expected to inhibit the global market growth of tissue expanders during the forecast period.

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=340

As need for reconstructing and uplifting breast arises, demand for anatomical tissue expanders is projected to increase globally. In terms of revenue, the anatomical tissue expanders product type segment is projected to witness robust growth in terms of revenue, recording for more than US$ 100 Mn by 2026-end. Further, the anatomical tissue expanders product type segment is projected to reflect significant CAGR throughout the forecast period.

Growing prevalence of breast cancer is projected to rev up demand for tissue expanders globally. Moreover, increasing demand for reconstruction of face, neck and forehead due to injuries is projected to impact the global market growth of tissue expanders positively. Fact.MR states that the global market of tissue expanders is projected to reflect a CAGR of 6.9% over the forecast period, 2017-2026.

Major players in the global market of tissue expanders are Sientra Inc., PMT Corporation, Johnson & Johnson, Allergan Plc, Groupe Sebbin, Polytech Health & Aesthetics, AirXpanders Inc., Koken Co. Ltd., Guangzhou Wanhe Plastic Materials and GC Aesthetics.

For a detailed industry outlook, Get the Report Sample at: https://www.factmr.com/connectus/sample?flag=S&rep_id=340

About Us

Fact.MR’s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level – our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.

Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.

The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.

Contact Us

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
E: info@factmr.com
Blog: https://theheraldmedia.com/

Epistaxis Market Report Analysis and Market Insights for Highly Profitable Investment Decision

Nosebleed is a common medical condition among the North American population. During their lifetime, more than three-fifth of the population in the US and Canada suffer from epistaxis. Depending on the causative factor, the degree of epistaxis varies from person to person, and robust healthcare infrastructure in the region guarantees the best medical assistance for North Americans suffering from epistaxis. The report estimates that by the end of 2026, the epistaxis market in North America will be worth nearly US$ 90 Mn. The report further projects that the incidence of epistaxis will be considerably high in the Latin American region. Through 2026, Latin America will account for one-fourth revenue share in the global epistaxis market.

Read Report Summary: https://www.factmr.com/report/344/epistaxis-market

Key companies developing drugs on epistaxis have been profiled in the report. Ferring B.V., GlaxoSmithKline PLC, Smith & Nephew Plc., Medline Industries, Inc., Pfizer Inc., Ciron Drugs & Pharmaceuticals Pvt. Ltd., and Bristol-Myers Squibb Co. are expected to remain active in the expansion of the global epistaxis market through 2026.

In several emergency cases, oral doctors and maxillofacial surgeons are being called on in the hospitals to check the common case of nose-bleeding. This condition, medically known as epistaxis, has been one of the common pains for people through the age. Increasing exposure to physical traumas and harsh environment continue to factor the incidence of epistaxis across the globe.

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=344

From physical assault to entry of foreign particles, epistaxis can be caused from a range of factors, increasing the need for appropriate and easily available medicine. Manufacturers of drugs are actively developing improved drugs on epistaxis to help people control persistent bleeding from the nose. A recently-published report by Fact.MR projects that in 2017, nearly US$ 150 Mn worth of epistaxis medicine and drugs will be sold across the globe.

The study further expects that by the end of 2026, the global epistaxis market will be worth over US$ 230 Mn value, expanding at an estimated 5.2% CAGR during the forecast period, 2017-2026. Key factors driving the sales of epistaxis have been addressed and analyzed in the report. Research shows that common etiologies for epistaxis include blood dyscrasias, consumption of bioreactive medications, arteriovenous malformations, traumatic intubation, orthognathic surgeries, and oncological surgeries. Prevalence of such factors has necessitated the need for first-line medical assistance and management, which is greatly important for minimizing patient morbidity, and in worst cases, mortality. The report has considered several scenarios that project a robust growth in demand for epistaxis medicine in the foreseeable future.

To learn more about how the key growth influencers are shaping the market landscape, request for the Sample Report at: https://www.factmr.com/connectus/sample?flag=S&rep_id=344

Biomedical Refrigerators and Freezers Market Emerging Trends may Make Driving Growth Volatile

Vaccination management is becoming a major concern in various healthcare and research institutions. Growing need for storing biomedical samples at exact and accurate temperature will further fuel adoption of biomedical freezers and refrigerators globally. Moreover, growth of the cell therapy has significantly revved up production of medicines, custom-made vaccine products and blood transfusion. Increasing demand for storage of the biomedical samples and products attributed to growing need for cell therapy is further projected to boost demand for biomedical freezers and refrigerators. These factors will continue to impact growth of the global market of biomedical refrigerators and freezers throughout the forecast period.

Read Report Summary: https://www.factmr.com/report/343/biomedical-refrigerators-freezers-market

In addition, demand for biomedical freezers and refrigerators will further continue to increase due to growing investment in the research and development. Researchers are significantly focusing on development of various innovative treatment procedures and medical products for the treatment of various diseases. Development of innovative techniques and products has led to increasing demand for various biomedical samples globally. Educational institutions are also increasingly investing in research and development in collaboration with various healthcare institutions. Growing investment in research and development by various healthcare and educational institutions is projected to contribute towards the global market growth of biomedical refrigerators and freezers throughout the forecast period.

Growing developments in the biobanking technology has transformed various aspects of science including biospecimen science and biorepository. With the growing advancements in biobanking, adoption of automated technology and robotic processing and handling process of the samples is projected to make the process of biobanking more effective. Moreover, development of various software applications that helps in storage management of blood and other biomedical samples is further projected to impact the global market growth of biomedical refrigerators and freezers positively.

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=343

As the requirement for storing blood and blood derivatives arise, demand for the plazma freezers is projected to increase globally. In terms of revenue, the plazma freezers product type segment is projected to represent the highest growth, representing more than US$ 400 Mn by 2022-end. In contrary, the cryogenic storage systems product type segment is projected to reflect a significant CAGR throughout the forecast period.

By 2022-end, the hospitals end user segment is projected to represent a robust revenue growth, accounting for more than US$ 300 Mn by 2017-end. On the other hand, the research laboratories end user segment is projected to reflect a healthy CAGR over the forecast period. Growing prevalence of various diseases is projected to boost demand for vaccines in the healthcare institutions globally. In addition, increasing advancements in biobanking techniques is projected to impact the global market growth positively. Fact.MR states that the global market of biomedical refrigerators and freezers is projected to reflect a CAGR of 5.7% over the forecast period, 2017-2022.

Growth of the global biomedical refrigerators and freezers market is mainly bound to various macro-economic and micro-economic factors. Prevalence of various disorders is projected to boost demand for vaccines in various healthcare institutions. Treatment of various diseases will also continue to boost demand for blood and derivatives of blood. Biomedical freezers and refrigerators is projected to witness significant demand in the research laboratories, blood banks, educational institutions, hospitals and diagnostic centers. Surge in demand for storage of biomedical samples will continue to fuel adoption of biomedical refrigerator and freezers globally.

For a detailed industry outlook, Get the Report Sample at: https://www.factmr.com/connectus/sample?flag=S&rep_id=343

Urology Devices Market Increasing Demand with Leading Players to 2026

Moreover, surge in instances of childbirth and prostate surgery is further expected to contribute towards the global market growth of urology devices significantly. As childbirth surgery weakens the sphincter in women, they are more prone to urological diseases such as stress incontinence. In men, growing prevalence of prostate cancer requires a prostate gland, which could weaken the sphincter. Prevalence of diseases such as stress incontinence is further to rev up adoption of the urology devices in the healthcare industry. Growing incidence of kidney stone due to lack of water intake among old age people will also continue to fuel adoption of various urological diseases.

Request for the Report Summary: https://www.factmr.com/report/352/urology-devices-market

Untreated kidney stone diseases can result in other healthcare issues such as vomiting, persistent need to urinate, fever owing to infections in urinary tract. As demand for minimally treatment remains high, the healthcare professionals are significantly adopting shock wave lithotripsy devices for accurate treatment of kidney stones. Bound to these factors, the global market of urology devices is projected to witness significant growth through 2026.

In addition, manufacturers in the healthcare industry are concentrating on developing medical devices that offer minimally treatment process. Integration of leading technological developments in the medical devices enables the healthcare professionals to speed up the treatment process of the patients. The healthcare professionals are mainly adopting ultrasound or x-ray technology to trace stones in the kidney and disintegrate the stones into smaller fragments for smooth passage. Manufacturers are further focusing on integrating advanced technology in order to develop robot-assisted medical devices. Robot-assisted medical devices are mainly tailored for accurate treatment of particular urological disorders and offer surgical navigation in order to assist during the treatment process. Increasing demand for robot-assisted urology devices and minimally treatment procedures will continue to impact the global market growth of urology devices positively throughout the forecast period.

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=352

Prevalence of various chronic kidney disorders is projected to fuel demand for urological disorders for dialysis treatment. In terms of revenue, the dialysis devices product type segment is projected to witness the highest growth, recording more than US$ 2,100 Mn by 2026-end. In contrary, the robotic systems product type segment is projected to reflect significant CAGR over the forecast period.

By 2017-end, the hospitals and clinics end use segment is projected to generate significant revenues, accounting for more than US$ 1,500 Mn. However, the dialysis centers end use segment is projected to reflect a healthy CAGR throughout 2026. Throughout the forecast period, the cancer and BPH diseases segment is projected to reflect the fastest growth in the global market. On the other hand, the kidney disease segment is projected to witness robust revenue growth, recording more than US$ 2,400 Mn by 2026-end.

Major players in the global market of urology devices are Baxter International, Inc., Siemens AG, Stryker Corporation, Boston Scientific Corp, Cook Medical Inc., Olympus Corporation, Richard Wolf GmbH and KARL STORZ GmbH & Co. KG.

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=352

Depression Drugs Market Massive Growth, Demand by Segmentation, Region and Forecast to 2026

According to the World Health Organization (WHO), depression has become one of the common illnesses, affecting over 300 million people across the world. In the United States, approximately 10.3 million adults had experienced at least one major depressive episode that resulted in severe impairment, according to the National Institute of Mental Health (NIMH). High prevalence of such depressive episode was observed among people aged 18-25 (10.9%), female adults (8.5%), and male adults (4.8%). According to the Fact.MR study, although depression continues to be a major health issue, medical community and patients are encouraging a non-drug approach to reduce side effects and dependency. Healthcare providers and patients are focusing on cognitive behavior therapy (CBT) and mindfulness-based approaches to foster a long-term management of depression and other mental health issues.

Read Report Summary: https://www.factmr.com/report/3215/depression-drugs-market

The study finds that demand for depression drugs is also witnessing a decline as end-users have more coping options at their disposal. The huge popularity of mental health apps, such as Headspace, Calm, Moodnotes, Pacifica, and SuperBetter has given patients more control over how they manage depression. Considering the growing body of research supporting the use of meditation and cognitive behavior therapy, the proliferation of tech apps has witnessed a spike in the recent years. The study finds that depression drugs market will continue to be influenced by these evolutions.

North America and Europe are the two largest depression drugs market globally, owing to concentration of leading market players and increase in R&D of these drugs. While there has been a rising burden of mental illness such as bipolar I disorder and schizophrenia in China and India, lack of wide-ranging awareness regarding antidepressant medications (ADMs) is expected to negatively affect the growth of depression drugs market in the Asia Pacific region. Moreover, different therapies of depression are as efficacious as ADM and their effects are more enduring, which may create a hindrance in future expansion of depression drugs market, especially in Asia Pacific and Middle East & Africa.

To learn more about how the key growth influencers are shaping the market landscape, request for the Sample Report at: https://www.factmr.com/connectus/sample?flag=S&rep_id=3215

The depression drugs market, valued at over US$ 6.5 billion in 2017, is likely to witness bearishness in the near future, with a new report by Fact.MR estimating revenues to decline at a -2% CAGR. According to the study, although the prevalence rate of depression has gone up in the last decade, preference for cognitive behavior therapy (CBT) and awareness about the potential side effects has led to a decline in demand for depression drugs. The study finds that US continued to be at the forefront in terms of total depression drugs sold in 2018.

Some key players operating in the manufacturing of depression drugs are Otsuka Pharmaceutical Co., Ltd., Johnson & Johnson, Sebela Pharmaceutical Inc., GlaxoSmithKline plc, AstraZeneca plc, Eli Lilly and Company, Allergan USA, Inc., Takeda Pharmaceutical Company Ltd, Novartis AG, Pfizer, Inc., Alkermes Plc, H. Lundbeck, Bristol Myers Squibb Co., and Teva Pharmaceutical Industries Ltd.

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=3215

About Us

Fact.MR’s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level – our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.

Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.

The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.

Contact Us

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
E: info@factmr.com
Read the Blog: http://www.dailyhealthtribune.com

Dental Lasers Market In-Depth Research & SWOT Analysis by Major Companies to 2022

According to the CDC, around 47% adults aged 30 and above are observed to be affected by at least one form of periodontal diseases, while nearly 30% of adults of age 65-75 years are edentulous or devoid of natural teeth. Rising incidences of periodontal diseases such as bleeding in gums and untreated tooth decay may translate into the growth of dental lasers market. Growing preference for advanced dental care services for periodontal problems, dental caries, and gum related diseases are likely to push the demand for dental lasers.

Read Report Summary: https://www.factmr.com/report/172/dental-lasers-market

Owing to improved efficiency, less bleeding, comfortable treatment, and better control of soft tissue, dental lasers are widely accepted to be effective tools. The non-invasive painless laser technology has gained immense popularity for its ability to overcome the drawbacks of conventional dental treatments. With rise in purchasing power of consumers, there has been a surge in the demand for laser dentistry and cosmetic dentistry for applications in extraction of tooth, reconstruction and fabrication of dental prosthetic connections, and others. These factors will continue to augment the global expansion of dental lasers market.

North America is considered to be the largest market for dental lasers, growing at a double-digit CAGR over the forecast period, with market revenues estimated to surpass US$ 200 million by 2022-end. Growing incidences of dental problems coupled with rising geriatric demographic is expected to directly impact the growth of dental lasers market in the region.

To get Intensive Insights: https://www.factmr.com/connectus/sample?flag=RM&rep_id=172

The U.S. remains the most lucrative country for North America dental lasers market, accounting for more than 80% of the total share in 2017. Increase in the adoption of dental lasers among oral care specialists to provide the patients with minimal pain and quick healing will continue to propel the growth of dental lasers market in the developed nations of North America.

Yttrium aluminum garnet lasers are likely to be the fastest-selling and top-selling product in the dental lasers market, contributing more than 50% of the total revenue share throughout the forecast period. These lasers are considered to be highly useful in periodontal therapy and have positive effects in surgical pocket therapy.

Based on end user, dental clinics are likely to account for higher value share than hospitals in the dental lasers market. Adoption of advanced dental care services and utilization of different types of lasers with hybrid functions are foreseen the foster the contribution of dental clinics to the global dental lasers market.

Check out the Sample Report here: https://www.factmr.com/connectus/sample?flag=S&rep_id=172

About Us

Fact.MR’s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level – our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.

Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.

The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.

Contact Us

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
E: info@factmr.com
Read the Blog: http://www.dailyhealthtribune.com

Lewy Body Dementia Treatment Market Opportunities, Challenges, Strategies & Forecasts Report

Cholinesterase inhibitors will remain the topselling drugs for treating lewy body dementia, accounting for nearly 60% share in 2018. The demand for cholinesterase inhibitors will be followed by antipsychotic drugs owing to their minimal side effects in management of lewy body dementia.

Read Report Summary: https://www.factmr.com/report/1154/lewy-body-dementia-treatment-market

The study opines that macro-economic factors, including growing geriatric population, increasing per capita healthcare expenditure, and paradigm shift towards a value-based healthcare model will drive market growth. Increasing healthcare spending has the potential to directly impact the need for lewy body dementia diagnostics and treatment solutions, which, in turn, will create growth opportunities for stakeholders in the market.

As per the study, the funding for research and investments in drugs has increased significantly, owing to the increasing prevalence of mental health issues, especially in elderly population. According to the study, increase in the number of on-going clinical trials will pave way for more effective lewy body dementia treatment over existing options.

The adoption of drug manufacturing processes will lead to enhanced lewy body dementia treatment procedures. Moreover, the growing research and development initiatives in lewy body dementia treatment market will boost the efficiency of the existing lewy body dementia treatment choices, which in turn, will aid stakeholders in appealing to a wider consumer base.

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=1154

According to the study, the growing healthcare facilities in developing countries, with a high prevalence of lewy body dementia, are creating lucrative growth opportunity for key pharmaceutical companies. Key players in lewy body dementia treatment market are adopting unique strategies, such as capacity expansion, novel product launches, and adoption of innovation-driven products, to increase the sales of their offerings in diverse geographies. Additionally, companies in lewy body dementia treatment market are entering into strategic alliances with other pharmaceutical companies and government bodies for faster development of present pipeline drugs.

According to the Fact.MR study, North America is likely to account for nearly one-third share of the market. This can be attributed to the rapid shift in demand for lewy body dementia treatment in developed economies, which have progressive healthcare sector and healthy reimbursement scenario for expensive drug cost. Furthermore, the easy accessibility for such treatment due to the presence of concerned healthcare professionals is driving growth in North America lewy body dementia treatment market. The study anticipates East Asia to be the second lucrative market for lewy body dementia treatment, following North America.

As per the study, Brazil and China will remain highly promising markets in terms of upcoming collaborative research in lewy body dementia treatment, mainly in the pharmaceutical industry. The leading stakeholders in lewy body dementia treatment market are focusing on increasing their market share in the Asia Pacific market through strategic mergers and acquisition with regional players and investment groups, finds the study. Whereas, regional market players are building long-term relationships with direct end-users to sustain continuous revenue flow.

For a broader and insightful view of the competition landscape, request for the Sample report: https://www.factmr.com/connectus/sample?flag=S&rep_id=1154

About Us

Fact.MR’s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level – our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.

Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.

The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.

Contact Us

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
E: info@factmr.com
Read the Blog: http://www.dailyhealthtribune.com

Breathalyzer Market Know the Key Growth Drivers Developments and Innovations 2017-2022

Rising trends of alcohol consumption in parallel to the growing number of cars used as the primary mode of transportation have resulted in a large number of road accidents. As a result, surging demand for determining the blood alcohol content (BAC) from the government agencies is projected to positively impact the growth of the global breathalyzer market, especially in North America. According to the U.S. law, individuals with a BrAC level of 0.08% and over are prosecuted. In such cases, breathalyzer s are used as crucial evidence for criminal trials. In addition to alcohol, there is a notable increase in the proclivity of individuals for drugs consumption. As a result, the manufacturers of the breathalyzer market have been endeavoring towards enhancing the functionality of their products to detect the cases of drug abuse.

Read Report Summary: https://www.factmr.com/report/125/breathalyzer-market

According to the report, breathalyzer s also find their applications in the medical field. Surging demand for breathalyzer s in diagnostics centers and hospitals is attributed to the excellent ability of such devices to diagnose asthma, tuberculosis, and pylori infection, which in turn, eliminates the need for multiple blood sample tests. This paves way for the growth of the global breathalyzer market.

Fact.MR predicts limited growth opportunities for the global breathalyzer market, owing to the inefficiency of the devices to detect alcohol from other chemical compounds consisting of a methyl group structure. Additionally, lip glosses, mouthwash, dentures, and asthma inhalers can modify the results of the devices. Such inaccuracies in the results could pose a challenge to the adoption rate of these devices. Another crucial restraint for the breathalyzer market is the unhygienic conditions and rising health concerns, owing to which drivers hesitate to undergo such tests.

As per the report, fuel cell technology is more favored over semiconductor sensor technology, on account of its portability, alcohol specificity, and accuracy. Fact.MR forecasts that the fuel cell segment will register a valuation of over US$ 380 Mn in the breathalyzer market by 2019. The technology holds over half of the total revenue acquired by the global breathalyzer market and it is predicted to hold the largest share in the technological segment with North America contributing massively to its growth.

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=125

The Fact.MR research report analyzes the breathalyzer market for the period 2012 – 2022. According to the study, the global breathalyzer market is expected to grow at a promising CAGR through 2022.

According to Fact.MR, the global breathalyzer market was valued at US$ 600 Mn in 2018, and it is anticipated to clock 7.5% Y-o-Y over 2018 to surpass US$ 645 Mn by 2019 end. The recently published report by Fact.MR analyses the growth prospects of the global breathalyzer market by studying several key influencing factors.

The study finds that the rising demand for breathalyzer s in the government agencies for law enforcement applications will continue to gain traction in 2019 with an estimated valuation of US$ 250 Mn by the year end. Such proliferated rate of adoption of breathalyzer s has encouraged the manufacturers to devise feature-rich and portable devices with utmost efficiency. As a result, a notable shift towards the convergence of technological innovation and breathalyzer devices is witnessed with an aim to provide utmost accuracy.

To learn more about how the key growth influencers are shaping the market landscape, request for the Sample Report at: https://www.factmr.com/connectus/sample?flag=S&rep_id=125

About Us

Fact.MR’s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level – our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.

Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.

The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.

Contact Us

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
E: info@factmr.com
Read the Blog: http://www.dailyhealthtribune.com

Controlled Substances Market Plying for Significant Growth During 2018-2028

Approval of medical marijuana has been on a significant uptick in various states of the US, trailed by the legalization in Canada for both recreational and medicinal use recently. This has tremendously contributed to the popularity of cannabis stocks, alongside efforts of leading controlled substance manufacturers toward eliminating legal barriers and attracting investor interest. The study estimates marijuana sales in 2019 to record a Y-o-Y growth at 9.3% over 2018.

Request for the Report Summary: https://www.factmr.com/report/2032/controlled-substances-market

“The Schedule of Controlled Substances currently positions marijuana in Schedule 1 – the most restrictive one reserved for “high potential for abuse,” “lack of accepted safety” and “no accepted medical use” drugs. Federal scheduling of marijuana has been a key concern among producers and medical patients alike, despite legalization of cannabis in the US and Canada. The US Drug Enforcement Administration has recently removed cannabidiol from Schedule 1, post-FDA approval of non-synthetic, cannabis-derived medicine. Marijuana businesses have cheered the DEA’s action, as it alludes the beginning of regulatory relaxation to the cannabis industry,” according to a lead analyst at Fact.MR.

The study opines that pain management will continue to account for over one-fourth share of the controlled substances market in 2018. Several regulatory norms being implemented in the prescription of controlled substances for pain management, such as in Georgia, Michigan, and Florida, have further triggered the preference and adoption of controlled substances to manage and treat chronic as well as acute pain. Attention deficit hyperactivity disorder (ADHD), and anxiety are other medical conditions wherein controlled substances are expected to witness promising future prospects, according to the study.

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=2032

The entrance of pharmaceutical giants in the cannabis sector of Canada alludes the next significant trend in the controlled substances industry, offering additional credibility to the sector. Although the pharmaceutical part of the expression involves the missing link, an ongoing trend of M&A and entrance of these legacy industries is poised in 2019 and the foreseeable future. There has been a drought in direct investments from the pharmaceutical industries in the licensed medical marijuana producers, it is highly likely that the trend would change, as the US witnesses the federal legalization of cannabis. Big pharmaceutical companies that eye collaborations and partnerships with cannabis producers having competitive differentiation circling their R&D initiatives, commercialization efforts, and clinical trial programs, are likely to witness significant revenue generation in the near future.

Ensuring effective and safe management of controlled drugs continues to remain an imperative agenda among pharmacists, which in turn has led the focus on fundamental changes including reviewing of liquid CD management and CD documentation to realize substantial improvements. The pharmacists are also adhering to the operational standards, completely aware about the way CDs are managed, along with identifying potential drawbacks and reporting concerns regarding non-conformance. This will result in adherence to appropriate steps that ensure apt prescription of quantities when dispensing controlled substances to patients.

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=2032

About Us

Fact.MR’s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level – our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.

Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.

The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.

Contact Us

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
E: info@factmr.com
Read the Blog: http://www.dailyhealthtribune.com

Operating Room Equipment Market Plying for Significant Growth During 2022

The study finds that healthcare professionals and surgeons are demanding for operating rooms equipped with technically advanced devices that provide greater flexibility and ease of handling in order to ensure improved operational efficiency and better patient care system. Moreover, hospitals are heavily investing to upgrade operating rooms to reduce post-operative trauma and hospital stays for patients. These factors are directly influencing the global expansion of operating room equipment market. Further, growing adoption of various complex surgical equipment ranging from movables imagining system to operating room lights in hospitals and ambulatory surgical centers is foreseen to guide the future of global operating room equipment market.

Request for the Report Summary: https://www.factmr.com/report/192/operating-room-equipment-market

In the recent times, electrosurgical technologies have been gaining rising momentum among manufacturers in operating room equipment market, which enable treatment such as incision of sealing wounds using electrical energy. Apart from this trend, healthcare professionals are showing strong preference for advanced surgical procedures that use patient imaging scans and virtual reality as compared to conventional techniques for treating medical infections and diseases. Owing to these factors, global operating room equipment market is anticipated to project a robust growth in the coming years.

According to the Fact.MR study, worldwide sales of movable imaging system collected a revenue of more than US$ 7.9 billion in 2017, and will continue to account for relatively large percentage share of operating room equipment market in 2018. Biomedical systems, on the other hand, is likely to witness an increasing demand in the coming years, representing second highest revenue growth in the global market of operating room equipment.

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=192

The study opines that hospitals will remain the largest end user of operating room equipment across the globe, holding a value share of more than 80% in 2017. Surge in the number of hospitals, especially in emerging economies, and upgrade in operating rooms with technically advanced devices will possibly push the demand for operating room equipment in hospitals.

The study highlights detailed profiles of leading players in the global operating room equipment market which include Getinge AB, Stryker Corporation, Steris Plc, Hill-Rom Holdings, Inc., General Electric Company, KARL STORZ GmbH & Co. KG, Mizuho OSI, Inc., Medtronic, plc, Koninklijke Philips N.V., and Dragerwerk AG & Co. KGaA.

The Fact.MR study offers a detailed analysis and an accurate forecast of global operating room equipment market for the 2017-2022 period. The global operating room market is projected to grow at a CAGR of 6.2% during the forecast period.

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=192

About Us

Fact.MR’s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level – our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.

Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.

The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.

Contact Us

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
E: info@factmr.com
Read the Blog: http://www.dailyhealthtribune.com